oliven
11 minutes ago
Most posters confuse the share price that's obviously manipulated with the company's value,
When Nasrat sells ELITE, many factors will be consider but not the s/p that's irrelevant in the negotiation.
If the buyer is a foreign pharma in need of the American market, they'll pay a super